CeriBell (CBLL) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CeriBell (CBLL) has outperformed Pacific Biosciences of California (PACB) over the past year, gaining 99.0% versus a gain of 94.3%. CeriBell is the larger company by market cap ($901.1 million vs $845.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | PACB |
|---|---|---|
| Share price | $23.48 | $2.72 |
| Market cap | $901.12M | $845.46M |
| 1-day change | -3.53% | +0.74% |
| YTD return | +7.07% | +45.45% |
| 1-year return | +98.98% | +94.29% |
| 5-year return | — | -88.85% |
| EPS (TTM) | $-1.76 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $3.44 |
| 52-week low | $10.85 | $1.07 |
| Distance from 52-week high | -8.38% | -20.93% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +21.68% | -20.59% |
| Average volume | 369.87K | 9.85M |
| Shares outstanding | 38.38M | 310.83M |
| Employees | 327 | 485 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: CeriBell in Health Care and Pacific Biosciences of California in Industrials.
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
CBLL vs PACB FAQ
Which is bigger, CeriBell or Pacific Biosciences of California?
CeriBell (CBLL) is larger, with a market capitalization of $901.12M compared with $845.46M for Pacific Biosciences of California (PACB).
Which stock has performed better over the past year, CBLL or PACB?
CBLL returned +98.98% over the past 12 months, compared with +94.29% for PACB (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and Pacific Biosciences of California in the same industry?
No. CeriBell is in the Health Care sector, while Pacific Biosciences of California is in Industrials.